Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Hess

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Swiss Medical Weekly|May 12, 2010
Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendationsC Taverna, M Bargetzi, D Betticher, et al.
Journal of Internal Medicine|March 25, 2005
Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvementP Chopard, J Dörffler-Melly, U Hess, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 1998
Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK)D C Betticher, D Ratschiller, S F Hsu Schmitz, et al.
Scientific Reports|September 2, 2023
Atmosphere injection of sea salts during large explosive submarine volcanic eruptionsM Colombier, I A Ukstins, S Tegtmeier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II studyA von Rohr, S-F H Schmitz, A Tichelli, et al.
Journal of Leukocyte Biology|February 20, 2019
Human liver-derived CXCR6<sup>+</sup> NK cells are predominantly educated through NKG2A and show reduced cytokine productionSebastian Lunemann, Annika E Langeneckert, Gloria Martrus, et al.
Journal of Hepatology|June 8, 2019
Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in miceGevitha Ravichandran, Katrin Neumann, Laura K Berkhout, et al.
Bone Marrow Transplantation|December 20, 2016
Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experienceJ Meissner, H Finel, S Dietrich, et al.
Leukemia|May 17, 2003
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)M Oosterveld, S Suciu, G Verhoef, et al.
European Journal of Immunology|February 21, 2019
CCL21-expression and accumulation of CCR7<sup>+</sup> NK cells in livers of patients with primary sclerosing cholangitisAnnika E Langeneckert, Sebastian Lunemann, Glòria Martrus, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Swiss Medical Weekly|May 12, 2010
Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendationsC Taverna, M Bargetzi, D Betticher, et al.
Journal of Internal Medicine|March 25, 2005
Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvementP Chopard, J Dörffler-Melly, U Hess, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 1998
Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK)D C Betticher, D Ratschiller, S F Hsu Schmitz, et al.
Scientific Reports|September 2, 2023
Atmosphere injection of sea salts during large explosive submarine volcanic eruptionsM Colombier, I A Ukstins, S Tegtmeier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II studyA von Rohr, S-F H Schmitz, A Tichelli, et al.
Journal of Leukocyte Biology|February 20, 2019
Human liver-derived CXCR6<sup>+</sup> NK cells are predominantly educated through NKG2A and show reduced cytokine productionSebastian Lunemann, Annika E Langeneckert, Gloria Martrus, et al.
Journal of Hepatology|June 8, 2019
Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in miceGevitha Ravichandran, Katrin Neumann, Laura K Berkhout, et al.
Bone Marrow Transplantation|December 20, 2016
Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experienceJ Meissner, H Finel, S Dietrich, et al.
Leukemia|May 17, 2003
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)M Oosterveld, S Suciu, G Verhoef, et al.
European Journal of Immunology|February 21, 2019
CCL21-expression and accumulation of CCR7<sup>+</sup> NK cells in livers of patients with primary sclerosing cholangitisAnnika E Langeneckert, Sebastian Lunemann, Glòria Martrus, et al.
Pageof 10